These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24123726)

  • 1. Gene-based therapies of neuromuscular disorders: an update and the pivotal role of patient organizations in their discovery and implementation.
    Braun S
    J Gene Med; 2013; 15(11-12):397-413. PubMed ID: 24123726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotherapies of neuromuscular disorders.
    Briand JF; Roy MO; Mourlane F; André C; Loux N; Rougeau C; Toursel T; Braun S
    Rev Neurol (Paris); 2014 Dec; 170(12):799-807. PubMed ID: 25459122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on RNA-targeting therapies for neuromuscular disorders.
    Jirka S; Aartsma-Rus A
    Curr Opin Neurol; 2015 Oct; 28(5):515-21. PubMed ID: 26280937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy update in nerve, neuromuscular junction and myopathic disorders.
    Sadeghian H; Wolfe GI
    Curr Opin Neurol; 2010 Oct; 23(5):496-501. PubMed ID: 20664347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene and splicing therapies for neuromuscular diseases.
    Benchaouir R; Robin V; Goyenvalle A
    Front Biosci (Landmark Ed); 2015 Jun; 20(8):1190-233. PubMed ID: 25961553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-targeting approaches for neuromuscular diseases.
    Le Roy F; Charton K; Lorson CL; Richard I
    Trends Mol Med; 2009 Dec; 15(12):580-91. PubMed ID: 19906562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Genetic Survey and Potential Gene-Targeting Therapeutics for Neuromuscular Diseases.
    Chiu W; Hsun YH; Chang KJ; Yarmishyn AA; Hsiao YJ; Chien Y; Chien CS; Ma C; Yang YP; Tsai PH; Chiou SH; Lin TY; Cheng HM
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pharmacotherapies for genetic neuromuscular disorders: opportunities and challenges.
    Ricci F; Vacchetti M; Brusa C; Vercelli L; Davico C; Vitiello B; Mongini T
    Expert Rev Clin Pharmacol; 2019 Aug; 12(8):757-770. PubMed ID: 31220956
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuromuscular disease and the pulmonologist.
    Yuan N
    Curr Opin Pediatr; 2012 Jun; 24(3):336-43. PubMed ID: 22498673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited neuromuscular disorders: pathway to diagnosis.
    Menezes MP; North KN
    J Paediatr Child Health; 2012 Jun; 48(6):458-65. PubMed ID: 22050238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene therapies for neuromuscular diseases].
    Saffari A; Weiler M; Hoffmann GF; Ziegler A
    Nervenarzt; 2019 Aug; 90(8):809-816. PubMed ID: 31286145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-based therapies for neuromuscular disorders.
    Zanoteli E; França MC; Marques W
    Arq Neuropsiquiatr; 2024 Jun; 82(6):1-10. PubMed ID: 38325390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seeking a better landscape for therapy development in neuromuscular disorders.
    Larkindale J; Porter JD
    Muscle Nerve; 2018 Jan; 57(1):16-19. PubMed ID: 28881009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing.
    Verdile V; Guizzo G; Ferrante G; Paronetto MP
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on best practices for gene therapy programs.
    Cheever TR; Berkley D; Braun S; Brown RH; Byrne BJ; Chamberlain JS; Cwik V; Duan D; Federoff HJ; High KA; Kaspar BK; Klinger KW; Larkindale J; Lincecum J; Mavilio F; McDonald CL; McLaughlin J; Weiss McLeod B; Mendell JR; Nuckolls G; Stedman HH; Tagle DA; Vandenberghe LH; Wang H; Wernett PJ; Wilson JM; Porter JD; Gubitz AK
    Hum Gene Ther; 2015 Mar; 26(3):127-33. PubMed ID: 25654329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Treatments for Inherited Neuromuscular Diseases of Childhood.
    Fay AJ; Knox R; Neil EE; Strober J
    Semin Neurol; 2020 Jun; 40(3):335-341. PubMed ID: 32294764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in neuromuscular disorders.
    D'Angelo MG; Bresolin N
    Muscle Nerve; 2006 Jul; 34(1):16-33. PubMed ID: 16544320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis of inheritable neuromuscular disorders. Part II: Application of genetic testing in neuromuscular disease.
    Greenberg SA; Walsh RJ
    Muscle Nerve; 2005 Apr; 31(4):431-51. PubMed ID: 15704143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular disorders in the omics era.
    Dabaj I; Ducatez F; Marret S; Bekri S; Tebani A
    Clin Chim Acta; 2024 Jan; 553():117691. PubMed ID: 38081447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular therapies in childhood neuromuscular disorders-definite hope versus unknown pitfalls].
    Blaschek A; Vill K; Müller-Felber W; Schara U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jul; 63(7):891-897. PubMed ID: 32542436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.